Canadian Ebola Vaccine to Start Clinical Trials Today

The video discusses the development of vaccines by various companies, focusing on a Canadian company and GlaxoSmithKline. GlaxoSmithKline's vaccine is in advanced testing, aiming to provide doses by January for healthcare workers in Africa. The Canadian vaccine is in early testing, with hopes to scale production. Challenges include producing enough doses quickly, especially for smaller companies like Profectus, and ensuring global distribution if the vaccine proves effective.

Which company has a vaccine that is the furthest along in testing?

• Moderna

• Pfizer

• GlaxoSmithKline

• Profectus

What is the main goal of the early human testing for the Canadian vaccine?

• To determine the cost of production

• To compare it with other vaccines

• To ensure the vaccine is safe

• To test the vaccine's effectiveness

What is a significant challenge faced by the Canadian company Profectus?

• Lack of funding

• Limited production capacity

• Regulatory hurdles

• Competition from other vaccines

Why might Profectus need a partner in the vaccine production process?

• To improve vaccine efficacy

• To scale up production

• To conduct more research

• To market the vaccine

What is the ultimate goal if the Canadian vaccine proves effective?

• To vaccinate only healthcare workers

• To distribute it globally

• To sell it to the highest bidder

• To use it only in Canada